Tick-borne Encephalitis Vaccine Market
1 Study Coverage
1.1 Tick-borne Encephalitis Vaccine Product Introduction
1.2 Global Tick-borne Encephalitis Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tick-borne Encephalitis Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Tick-borne Encephalitis Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Tick-borne Encephalitis Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Tick-borne Encephalitis Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Tick-borne Encephalitis Vaccine Sales in Volume for the Year 2017-2028
1.4 Tick-borne Encephalitis Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Tick-borne Encephalitis Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Tick-borne Encephalitis Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Tick-borne Encephalitis Vaccine Market Dynamics
1.5.1 Tick-borne Encephalitis Vaccine Industry Trends
1.5.2 Tick-borne Encephalitis Vaccine Market Drivers
1.5.3 Tick-borne Encephalitis Vaccine Market Challenges
1.5.4 Tick-borne Encephalitis Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Tick-borne Encephalitis Vaccine Market Segment by Type
2.1.1 European TBE Virus
2.1.2 Far Eastern TBE Virus
2.1.3 Siberian TBE Virus
2.2 Global Tick-borne Encephalitis Vaccine Market Size by Type
2.2.1 Global Tick-borne Encephalitis Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Tick-borne Encephalitis Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Tick-borne Encephalitis Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Tick-borne Encephalitis Vaccine Market Size by Type
2.3.1 United States Tick-borne Encephalitis Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Tick-borne Encephalitis Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Tick-borne Encephalitis Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Tick-borne Encephalitis Vaccine Market Segment by Application
3.1.1 Pediatric Vaccines
3.1.2 Adult Vaccines
3.1.3 Traveler Vaccines
3.2 Global Tick-borne Encephalitis Vaccine Market Size by Application
3.2.1 Global Tick-borne Encephalitis Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Tick-borne Encephalitis Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Tick-borne Encephalitis Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Tick-borne Encephalitis Vaccine Market Size by Application
3.3.1 United States Tick-borne Encephalitis Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Tick-borne Encephalitis Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Tick-borne Encephalitis Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Tick-borne Encephalitis Vaccine Competitor Landscape by Company
4.1 Global Tick-borne Encephalitis Vaccine Market Size by Company
4.1.1 Top Global Tick-borne Encephalitis Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Tick-borne Encephalitis Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Tick-borne Encephalitis Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Tick-borne Encephalitis Vaccine Price by Manufacturer (2017-2022)
4.2 Global Tick-borne Encephalitis Vaccine Concentration Ratio (CR)
4.2.1 Tick-borne Encephalitis Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Tick-borne Encephalitis Vaccine in 2021
4.2.3 Global Tick-borne Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tick-borne Encephalitis Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Tick-borne Encephalitis Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Tick-borne Encephalitis Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Tick-borne Encephalitis Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Tick-borne Encephalitis Vaccine Market Size by Company
4.5.1 Top Tick-borne Encephalitis Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tick-borne Encephalitis Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Tick-borne Encephalitis Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Tick-borne Encephalitis Vaccine Market Size by Region
5.1 Global Tick-borne Encephalitis Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tick-borne Encephalitis Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Tick-borne Encephalitis Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Tick-borne Encephalitis Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Tick-borne Encephalitis Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Tick-borne Encephalitis Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Tick-borne Encephalitis Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tick-borne Encephalitis Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Tick-borne Encephalitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tick-borne Encephalitis Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tick-borne Encephalitis Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tick-borne Encephalitis Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Tick-borne Encephalitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tick-borne Encephalitis Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Tick-borne Encephalitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tick-borne Encephalitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Tick-borne Encephalitis Vaccine Products Offered
7.1.5 Pfizer Recent Development
7.2 Encephalitis
7.2.1 Encephalitis Corporation Information
7.2.2 Encephalitis Description and Business Overview
7.2.3 Encephalitis Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Encephalitis Tick-borne Encephalitis Vaccine Products Offered
7.2.5 Encephalitis Recent Development
7.3 Cochrane Collaboration
7.3.1 Cochrane Collaboration Corporation Information
7.3.2 Cochrane Collaboration Description and Business Overview
7.3.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cochrane Collaboration Tick-borne Encephalitis Vaccine Products Offered
7.3.5 Cochrane Collaboration Recent Development
7.4 Sonic HealthPlus
7.4.1 Sonic HealthPlus Corporation Information
7.4.2 Sonic HealthPlus Description and Business Overview
7.4.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sonic HealthPlus Tick-borne Encephalitis Vaccine Products Offered
7.4.5 Sonic HealthPlus Recent Development
7.5 Superdrug Health
7.5.1 Superdrug Health Corporation Information
7.5.2 Superdrug Health Description and Business Overview
7.5.3 Superdrug Health Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Superdrug Health Tick-borne Encephalitis Vaccine Products Offered
7.5.5 Superdrug Health Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Tick-borne Encephalitis Vaccine Industry Chain Analysis
8.2 Tick-borne Encephalitis Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Tick-borne Encephalitis Vaccine Distributors
8.3 Tick-borne Encephalitis Vaccine Production Mode & Process
8.4 Tick-borne Encephalitis Vaccine Sales and Marketing
8.4.1 Tick-borne Encephalitis Vaccine Sales Channels
8.4.2 Tick-borne Encephalitis Vaccine Distributors
8.5 Tick-borne Encephalitis Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Tick-borne Encephalitis Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Tick-borne Encephalitis Vaccine Market Trends
Table 3. Tick-borne Encephalitis Vaccine Market Drivers
Table 4. Tick-borne Encephalitis Vaccine Market Challenges
Table 5. Tick-borne Encephalitis Vaccine Market Restraints
Table 6. Global Tick-borne Encephalitis Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Tick-borne Encephalitis Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Tick-borne Encephalitis Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Tick-borne Encephalitis Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Tick-borne Encephalitis Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Tick-borne Encephalitis Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Tick-borne Encephalitis Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Tick-borne Encephalitis Vaccine Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Tick-borne Encephalitis Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Tick-borne Encephalitis Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Tick-borne Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Tick-borne Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tick-borne Encephalitis Vaccine as of 2021)
Table 18. Top Players of Tick-borne Encephalitis Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Tick-borne Encephalitis Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Tick-borne Encephalitis Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Tick-borne Encephalitis Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Tick-borne Encephalitis Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Tick-borne Encephalitis Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Tick-borne Encephalitis Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Tick-borne Encephalitis Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Tick-borne Encephalitis Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Tick-borne Encephalitis Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Tick-borne Encephalitis Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Tick-borne Encephalitis Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Tick-borne Encephalitis Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Tick-borne Encephalitis Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Tick-borne Encephalitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Tick-borne Encephalitis Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Tick-borne Encephalitis Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Tick-borne Encephalitis Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Tick-borne Encephalitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Tick-borne Encephalitis Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Tick-borne Encephalitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Tick-borne Encephalitis Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Tick-borne Encephalitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Pfizer Tick-borne Encephalitis Vaccine Product
Table 46. Pfizer Recent Development
Table 47. Encephalitis Corporation Information
Table 48. Encephalitis Description and Business Overview
Table 49. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Encephalitis Product
Table 51. Encephalitis Recent Development
Table 52. Cochrane Collaboration Corporation Information
Table 53. Cochrane Collaboration Description and Business Overview
Table 54. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Cochrane Collaboration Product
Table 56. Cochrane Collaboration Recent Development
Table 57. Sonic HealthPlus Corporation Information
Table 58. Sonic HealthPlus Description and Business Overview
Table 59. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. Sonic HealthPlus Product
Table 61. Sonic HealthPlus Recent Development
Table 62. Superdrug Health Corporation Information
Table 63. Superdrug Health Description and Business Overview
Table 64. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Superdrug Health Product
Table 66. Superdrug Health Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Tick-borne Encephalitis Vaccine Customers List
Table 70. Tick-borne Encephalitis Vaccine Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Tick-borne Encephalitis Vaccine Product Picture
Figure 2. Global Tick-borne Encephalitis Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Tick-borne Encephalitis Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Tick-borne Encephalitis Vaccine Sales 2017-2028 (K Doses)
Figure 5. United States Tick-borne Encephalitis Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Tick-borne Encephalitis Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Tick-borne Encephalitis Vaccine Sales 2017-2028 (K Doses)
Figure 8. United States Tick-borne Encephalitis Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Tick-borne Encephalitis Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Tick-borne Encephalitis Vaccine Report Years Considered
Figure 11. Product Picture of European TBE Virus
Figure 12. Product Picture of Far Eastern TBE Virus
Figure 13. Product Picture of Siberian TBE Virus
Figure 14. Global Tick-borne Encephalitis Vaccine Market Share by Type in 2022 & 2028
Figure 15. Global Tick-borne Encephalitis Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Tick-borne Encephalitis Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 18. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Tick-borne Encephalitis Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 20. United States Tick-borne Encephalitis Vaccine Market Share by Type in 2022 & 2028
Figure 21. United States Tick-borne Encephalitis Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Tick-borne Encephalitis Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 24. United States Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Tick-borne Encephalitis Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 26. Product Picture of Pediatric Vaccines
Figure 27. Product Picture of Adult Vaccines
Figure 28. Product Picture of Traveler Vaccines
Figure 29. Global Tick-borne Encephalitis Vaccine Market Share by Application in 2022 & 2028
Figure 30. Global Tick-borne Encephalitis Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Tick-borne Encephalitis Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 33. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Tick-borne Encephalitis Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 35. United States Tick-borne Encephalitis Vaccine Market Share by Application in 2022 & 2028
Figure 36. United States Tick-borne Encephalitis Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Tick-borne Encephalitis Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 39. United States Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Tick-borne Encephalitis Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 41. North America Tick-borne Encephalitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 42. North America Tick-borne Encephalitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Tick-borne Encephalitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 46. Europe Tick-borne Encephalitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Tick-borne Encephalitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 53. Asia-Pacific Tick-borne Encephalitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Tick-borne Encephalitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 65. Latin America Tick-borne Encephalitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Tick-borne Encephalitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 70. Middle East & Africa Tick-borne Encephalitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Tick-borne Encephalitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Tick-borne Encephalitis Vaccine Value Chain
Figure 75. Tick-borne Encephalitis Vaccine Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed